Task: Answer the multiple-choice question.
Question: Which drug exhibits a 14.242% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a) O=C(C1CCC(CNS(=O)(=O)c2ccc(F)cc2)CC1)N1CCOCC1
b) COc1ccc(/C=C2\SC(=S)N(CC3CCCO3)C2=O)cc1
c) CCCC(=O)N(Cc1cc(=O)[nH]c2ccccc12)c1cccc(C)c1
Answer: b. COc1ccc(/C=C2\SC(=S)N(CC3CCCO3)C2=O)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(/C=C2\SC(=S)N(CC3CCCO3)C2=O)cc1
COc1ccc(/C=C2\SC(=S)N(CC3CCCO3)C2=O)cc1
(5Z)-5-[(4-methoxyphenyl)methylidene]-3-(oxolan-2-ylmethyl)-2-sulfanylidene-1,3-thiazolidin-4-one